To strengthen the anabolic properties of testosterone, more than 100 synthetic steroid derivatives have been described for human purposes. The anabolic effect promotes protein synthesis, muscle growth and erythropoiesis. In clinical practice, substances with anabolic effect are needed to overcome various catabolic states. However, none of these compounds are devoid of androgenicity. Androgenic and anabolic properties of anabolic steroids cannot be totally separated. Therefore, it is more appropriate to use the term anabolic androgenic steroids (AAS).
Winstrol is the oral version of stanozolol and is a derivative of dihydrotestosterone, and exhibits mild anabolic effects while significantly increasing lean body mass and reducing overall body fat composition. WinMax is moderately hepatotoxic and can produce a moderate increase in blood pressure at higher dosages. Winstrol does not aromatize and does not significantly alter endogenous testosterone production at low doses. Winstrol is indicated for replacement therapy in males for conditions associated with deficiency or absence of endogenous testosterone. Primary hypogonadism (congenital or acquired), testicular failure due to cryptorchidism, bilateral torsion, orchitis, vanishing testis syndrome, or orchidectomy. Hypogonadotropic hypogonadism (congenital or acquired), idiopathic gonadotropin or LHRH deficiency, or pituitary-hypothalamic injury from tumors, trauma, or radiation.